These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

304 related items for PubMed ID: 34741044

  • 1. STEAP3 promotes cancer cell proliferation by facilitating nuclear trafficking of EGFR to enhance RAC1-ERK-STAT3 signaling in hepatocellular carcinoma.
    Wang LL, Luo J, He ZH, Liu YQ, Li HG, Xie D, Cai MY.
    Cell Death Dis; 2021 Nov 05; 12(11):1052. PubMed ID: 34741044
    [Abstract] [Full Text] [Related]

  • 2. T-box transcription factor 19 promotes hepatocellular carcinoma metastasis through upregulating EGFR and RAC1.
    Ji X, Chen X, Zhang B, Xie M, Zhang T, Luo X, Liu D, Feng Y, Wang Y, Sun M, Li C, Huang W, Xia L.
    Oncogene; 2022 Apr 05; 41(15):2225-2238. PubMed ID: 35217793
    [Abstract] [Full Text] [Related]

  • 3. miR-500a-3p promotes cancer stem cells properties via STAT3 pathway in human hepatocellular carcinoma.
    Jiang C, Long J, Liu B, Xu M, Wang W, Xie X, Wang X, Kuang M.
    J Exp Clin Cancer Res; 2017 Jul 27; 36(1):99. PubMed ID: 28750679
    [Abstract] [Full Text] [Related]

  • 4. Anticancer activity of dietary xanthone α-mangostin against hepatocellular carcinoma by inhibition of STAT3 signaling via stabilization of SHP1.
    Zhang H, Tan YP, Zhao L, Wang L, Fu NJ, Zheng SP, Shen XF.
    Cell Death Dis; 2020 Jan 24; 11(1):63. PubMed ID: 31980595
    [Abstract] [Full Text] [Related]

  • 5. STK39 is a novel kinase contributing to the progression of hepatocellular carcinoma by the PLK1/ERK signaling pathway.
    Zhang C, Wang X, Fang D, Xu P, Mo X, Hu C, Abdelatty A, Wang M, Xu H, Sun Q, Zhou G, She J, Xia J, Hui KM, Xia H.
    Theranostics; 2021 Jan 24; 11(5):2108-2122. PubMed ID: 33500714
    [Abstract] [Full Text] [Related]

  • 6. LAGE3 promoted cell proliferation, migration, and invasion and inhibited cell apoptosis of hepatocellular carcinoma by facilitating the JNK and ERK signaling pathway.
    Xing Y, Liu Y, Qi Z, Liu Z, Wang X, Zhang H.
    Cell Mol Biol Lett; 2021 Nov 27; 26(1):49. PubMed ID: 34837962
    [Abstract] [Full Text] [Related]

  • 7. Ascochlorin, an isoprenoid antibiotic inhibits growth and invasion of hepatocellular carcinoma by targeting STAT3 signaling cascade through the induction of PIAS3.
    Dai X, Ahn KS, Kim C, Siveen KS, Ong TH, Shanmugam MK, Li F, Shi J, Kumar AP, Wang LZ, Goh BC, Magae J, Hui KM, Sethi G.
    Mol Oncol; 2015 Apr 27; 9(4):818-33. PubMed ID: 25624051
    [Abstract] [Full Text] [Related]

  • 8. Overexpression of chaperonin containing TCP1, subunit 3 predicts poor prognosis in hepatocellular carcinoma.
    Cui X, Hu ZP, Li Z, Gao PJ, Zhu JY.
    World J Gastroenterol; 2015 Jul 28; 21(28):8588-604. PubMed ID: 26229401
    [Abstract] [Full Text] [Related]

  • 9. NT5DC2 promotes tumor cell proliferation by stabilizing EGFR in hepatocellular carcinoma.
    Li KS, Zhu XD, Liu HD, Zhang SZ, Li XL, Xiao N, Liu XF, Xu B, Lei M, Zhang YY, Shi WK, Cao MQ, Xu YF, Tang ZY, Sun HC.
    Cell Death Dis; 2020 May 07; 11(5):335. PubMed ID: 32382041
    [Abstract] [Full Text] [Related]

  • 10. Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling.
    Yin X, Zhang BH, Zheng SS, Gao DM, Qiu SJ, Wu WZ, Ren ZG.
    J Hematol Oncol; 2015 Mar 11; 8():23. PubMed ID: 25879771
    [Abstract] [Full Text] [Related]

  • 11. Maintenance of stemness by miR-589-5p in hepatocellular carcinoma cells promotes chemoresistance via STAT3 signaling.
    Long J, Jiang C, Liu B, Dai Q, Hua R, Chen C, Zhang B, Li H.
    Cancer Lett; 2018 Jun 01; 423():113-126. PubMed ID: 29196128
    [Abstract] [Full Text] [Related]

  • 12. GNAS promotes inflammation-related hepatocellular carcinoma progression by promoting STAT3 activation.
    Ding H, Zhang X, Su Y, Jia C, Dai C.
    Cell Mol Biol Lett; 2020 Jun 01; 25():8. PubMed ID: 32123532
    [Abstract] [Full Text] [Related]

  • 13. PSMD9 promotes the malignant progression of hepatocellular carcinoma by interacting with c-Cbl to activate EGFR signaling and recycling.
    Su Y, Meng L, Ge C, Liu Y, Zhang C, Yang Y, Tian W, Tian H.
    J Exp Clin Cancer Res; 2024 May 14; 43(1):142. PubMed ID: 38745188
    [Abstract] [Full Text] [Related]

  • 14. Aquaporin 3 maintains the stemness of CD133+ hepatocellular carcinoma cells by activating STAT3.
    Wang Y, Wu G, Fu X, Xu S, Wang T, Zhang Q, Yang Y.
    Cell Death Dis; 2019 Jun 13; 10(6):465. PubMed ID: 31197130
    [Abstract] [Full Text] [Related]

  • 15. Loss of RDM1 enhances hepatocellular carcinoma progression via p53 and Ras/Raf/ERK pathways.
    Chen SL, Liu LL, Wang CH, Lu SX, Yang X, He YF, Zhang CZ, Yun JP.
    Mol Oncol; 2020 Feb 13; 14(2):373-386. PubMed ID: 31670863
    [Abstract] [Full Text] [Related]

  • 16. Endoplasmic reticulum resident oxidase ERO1-Lalpha promotes hepatocellular carcinoma metastasis and angiogenesis through the S1PR1/STAT3/VEGF-A pathway.
    Yang S, Yang C, Yu F, Ding W, Hu Y, Cheng F, Zhang F, Guan B, Wang X, Lu L, Rao J.
    Cell Death Dis; 2018 Oct 30; 9(11):1105. PubMed ID: 30377291
    [Abstract] [Full Text] [Related]

  • 17. Cellular retinol binding protein-1 inhibits cancer stemness via upregulating WIF1 to suppress Wnt/β-catenin pathway in hepatocellular carcinoma.
    Liu X, Shan W, Li T, Gao X, Kong F, You H, Kong D, Qiao S, Tang R.
    BMC Cancer; 2021 Nov 14; 21(1):1224. PubMed ID: 34775955
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.